Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram Acute Effects in Premenstrual Dysphoric Disorder
2012-000309-60Phase 4Active
- Sponsor
- University of Gothenburg
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of escitalopram in Premenstrual Dysphoric Disorder (PMDD), sponsored by University of Gothenburg. Primary endpoint: Serotonin levels in cerebrospinal fluid. Started Apr 2014; status: active.
02
Drugs
escitalopram
03
Conditions
Premenstrual Dysphoric Disorder (PMDD)
Beyond the preview
Go deeper on 2012-000309-60.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000309-60.